Document is current
Any future updates will be listed below
-
Authors
Li, Jing
Balmaceda, Pia
Ha, Thuy
Visker, Joseph R. https://orcid.org/0000-0002-8490-6111
Maalouf, Nicole
Kwan, Eugene
Hoareau, Guillaume L.
Accad, Michel
Ranjan, Ravi
Selzman, Craig H.
Drakos, Stavros G.
Shaw, Robin M.
Hong, TingTing https://orcid.org/0000-0002-0243-5046
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL159983, R01HL170196, R01HL159983, R01HL170196)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R21AG074593, R21AG074593)
- License Information
-
More Information
Article History
Received: 1 May 2024
Accepted: 12 November 2024
First Online: 10 December 2024
Competing interests
: The University of Utah has submitted a provisional patent application: “Methods for rehabilitating heart failure using gene therapy” (US 63/088, 123, TT.H. and R.M.S), which has been licensed by TikkunLev Inc. TT.H and R.M.S received a Sponsored Research Award and stock options from TikkunLev Inc. Disclosures for S.G.D.: Consultant: Abbott, Research Support: Novartis. No other conflict of interest exists. Other authors declare no competing interest.
